In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Jazz Pharmaceuticals plc

http://jazzpharma.com

Latest From Jazz Pharmaceuticals plc

Finance Watch: Inhibikase IPO Brought 2020 US Total To 87

Public Company Edition: The new year started with two companies signaling plans for significant near-term initial public offerings, following Inhibikase’s launch as the last IPO of 2020. Other recent financial highlights include layoffs at Calithera and Regenxbio’s $200m Zolgensma royalty sale.

Financing Business Strategies

Finance Watch: BioAtla, Virios And Scopus Launch Latest US IPOs

Public Company Edition: Initial public offerings may take a holiday break, but 2020 already has been a remarkable year for IPOs in the US and China. Also, Arvinas led the latest follow-ons with a $400m offering followed by TG Therapeutics with a $275m stock sale.

Financing Business Strategies

Keeping Track: Myovant, Almirall, MacroGenics Nab Novel Approvals; Novartis’ Inclisiran Delayed

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

US FDA Performance Tracker Approvals

EU Approvals Beckon For Inrebic & Novel Adalimumab Biosimilar

Inrebic, Celgene’s myelofibrosis treatment, and Yuflyma, Celltrion’s high-concentration adalimumab biosimilar, are among the latest new drugs that have been recommended for approval for use across the EU. Meanwhile, TETEC has withdrawn its EU marketing application for Artobend.

Europe Approvals
See All

Company Information

  • Industry
  • Biotechnology
  • Contract Manufacturing Organization
  • Biotechnology
    • Drug Discovery Tools
  • Other Names / Subsidiaries
    • Alizé Pharma II
    • Azur Pharma Public Limited Company
    • Cavion, Inc.
    • Cavion LLC (Tau Therapeutics LLC
    • Xdynia LLC)
    • Celator Pharmaceuticals, Inc.
    • EUSA Pharma Inc. (Cytogen Corporation
    • OPi SA)
    • Gentium S.p.A.
    • Jazz Pharmaceuticals Ireland Limited
    • Orphan Medical, Inc.
UsernamePublicRestriction

Register